These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7539177)

  • 1. Uroflowmetry and urodynamics.
    Kaplan SA; Te AE
    Urol Clin North Am; 1995 May; 22(2):309-20. PubMed ID: 7539177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
    Haab F
    Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment on: diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume.
    Gratzke C; Reich O
    Eur Urol; 2007 Sep; 52(3):835. PubMed ID: 17207917
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical value of uroflowmentry in selected cases of bladder outlet obstruction.
    Lemma BE; Taye M; Hawando T; Bakke A
    Ethiop Med J; 2004 Oct; 42(4):283-7. PubMed ID: 16122120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis?
    Gravina GL; Costa AM; Galatioto GP; Ronchi P; Tubaro A; Vicentini C
    J Urol; 2007 Sep; 178(3 Pt 1):959-63; discussion 963-4. PubMed ID: 17632142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urodynamic study in patients with prostatic hyperplasia].
    Shishido K; Yamaguchi O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():346-51. PubMed ID: 12599598
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of prostatic obstruction with a combination of isometric detrusor contraction pressure and maximum urinary flow rate.
    Comiter CV; Sullivan MP; Schacterle RS; Yalla SV
    Urology; 1996 Nov; 48(5):723-9; discussion 729-30. PubMed ID: 8911516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS
    Urology; 1996 Nov; 48(5):668-75. PubMed ID: 8911507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for urodynamic studies before and after adenomectomy].
    Lipsky H
    Z Urol Nephrol; 1982 Feb; 75(2):103-9. PubMed ID: 6176085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic verification of noninvasive back-pressure recordings from the urinary bladder.
    Walter JS; Andros G; Stokes S; Wheeler JS; Damaser M; Sacks J; Kadri I; Walter R
    Tech Urol; 1998 Dec; 4(4):185-91. PubMed ID: 9891999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.